NCT04557371

A Study to Assess the Local Cutaneous and Ocular Tolerance of Three Developmental Facial Skin-care Formulations.

A Clinical Study to Assess the Local Cutaneous and Ocular Tolerance of Three Developmental Cosmetic Facial Skin Care Formulations in Healthy Females With Clinically Assessed Sensitive Skin.

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 150 (actual)
• Sponsor: GlaxoSmithKline · Industry
• Sex: Female
• Age: 18 Years – 65 Years
• Healthy volunteers: Accepted

Summary

This study aims to determine the local cutaneous and ocular tolerance of 3 developmental skin-care products; a serum, a lotion, and a cream in healthy female subjects with clinically evaluated sensitive facial skin for 21 days.

Detailed description

This will be a randomized, non-comparative, single-blind (evaluator), 3-arm, parallel-group, single-center, clinical 'in-use' study to determine the local cutaneous and ocular tolerance profiles of 3 developmental cosmetic facial skincare products; a serum, lotion, and cream in healthy females with clinically-evaluated sensitive skin as determined by a positive response to a Lactic Acid Stinging Test (LAST) with signs or symptoms of cutaneous irritation and no ophthalmological conditions. Assessments will be performed and recorded for 21 days.

Conditions

• Skin Care

Interventions

Type	Name	Description
OTHER	Serum	Participants will topically apply the serum to the face as per normal home use application in place of their current facial serum product.
OTHER	Lotion	Participants will topically apply lotion to the face as per normal home use application in place of their current facial lotion product.
OTHER	Cream	Participants will topically apply cream to the face as per normal home use application in place of their current facial cream product.

Timeline

• Start date: 2020-10-12
• Primary completion: 2020-12-22
• Completion: 2020-12-22
• First posted: 2020-09-21
• Last updated: 2022-04-22
• Results posted: 2022-04-22

Locations

1 site across 1 country: Germany